Martin Bornhauser
Martin Bornhauser
Unknown affiliation
Verified email at uniklinikum-dresden.de
Title
Cited by
Cited by
Year
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis …
C Thiede, C Steudel, B Mohr, M Schaich, U Schäkel, U Platzbecker, ...
Blood, The Journal of the American Society of Hematology 99 (12), 4326-4335, 2002
18712002
Mesenchymal stem cells can be differentiated into endothelial cells in vitro
J Oswald, S Boxberger, B Jørgensen, S Feldmann, G Ehninger, ...
Stem cells 22 (3), 377-384, 2004
16742004
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open …
J Finke, WA Bethge, C Schmoor, HD Ottinger, M Stelljes, AR Zander, ...
The lancet oncology 10 (9), 855-864, 2009
6282009
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk …
C Schmid, M Labopin, A Nagler, M Bornhäuser, J Finke, A Fassas, ...
Journal of clinical oncology 25 (31), 4938-4945, 2007
4532007
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)
B Wassmann, H Pfeifer, N Goekbuget, DW Beelen, J Beck, M Stelljes, ...
Blood 108 (5), 1469-1477, 2006
4152006
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party …
N Kröger, E Holler, G Kobbe, M Bornhäuser, R Schwerdtfeger, ...
Blood, The Journal of the American Society of Hematology 114 (26), 5264-5270, 2009
4072009
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
JJ Cornelissen, A Gratwohl, RF Schlenk, J Sierra, M Bornhaeuser, ...
Nature reviews Clinical oncology 9 (10), 579-590, 2012
3732012
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
U Platzbecker, M Wermke, J Radke, U Oelschlaegel, F Seltmann, A Kiani, ...
Leukemia 26 (3), 381-389, 2012
3642012
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
M Von Bonin, F Stölzel, A Goedecke, K Richter, N Wuschek, K Hölig, ...
Bone marrow transplantation 43 (3), 245-251, 2009
3392009
Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection
C Thiede, M Florek, M Bornhäuser, M Ritter, B Mohr, C Brendel, ...
Bone Marrow Transplantation 23 (10), 1055-1060, 1999
3241999
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation
RF Chemaly, AJ Ullmann, S Stoelben, MP Richard, M Bornhäuser, ...
New England Journal of Medicine 370 (19), 1781-1789, 2014
3202014
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2 …
C Röllig, H Serve, A Hüttmann, R Noppeney, C Müller-Tidow, U Krug, ...
The lancet oncology 16 (16), 1691-1699, 2015
3082015
Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia …
J Donadieu, T Leblanc, BB Meunier, M Barkaoui, O Fenneteau, ...
haematologica 90 (1), 45-53, 2005
3062005
The 2017 magnetism roadmap
D Sander, SO Valenzuela, D Makarov, CH Marrows, EE Fullerton, ...
Journal of Physics D: Applied Physics 50 (36), 363001, 2017
2932017
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius
G Socié, C Schmoor, WA Bethge, HD Ottinger, M Stelljes, AR Zander, ...
Blood, The Journal of the American Society of Hematology 117 (23), 6375-6382, 2011
2912011
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD
K Rieger, C Loddenkemper, J Maul, T Fietz, D Wolff, H Terpe, B Steiner, ...
Blood 107 (4), 1717-1723, 2006
2882006
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German …
J Schetelig, C Thiede, M Bornhauser, R Schwerdtfeger, M Kiehl, J Beyer, ...
Journal of Clinical Oncology 21 (14), 2747-2753, 2003
2832003
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis
J Schetelig, A Van Biezen, R Brand, D Caballero, R Martino, M Itala, ...
J Clin Oncol 26 (31), 5094-5100, 2008
2752008
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research
S Arai, M Arora, T Wang, SR Spellman, W He, DR Couriel, ...
Biology of Blood and Marrow Transplantation 21 (2), 266-274, 2015
2652015
Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting …
C Röllig, M Bornhäuser, C Thiede, F Taube, M Kramer, B Mohr, W Aulitzky, ...
Journal of clinical oncology 29 (20), 2758-2765, 2011
2522011
The system can't perform the operation now. Try again later.
Articles 1–20